CorMedix, Inc. (CRMD)
8.28
+0.08
(+0.98%)
USD |
NASDAQ |
Aug 24, 16:00
8.28
0.00 (0.00%)
After-Hours: 07:03
CorMedix Net Income (Quarterly) : 25.99M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.99M |
| March 31, 2026 | 38.60M |
| December 31, 2025 | 14.02M |
| September 30, 2025 | 108.56M |
| June 30, 2025 | 19.83M |
| March 31, 2025 | 20.64M |
| December 31, 2024 | 13.46M |
| September 30, 2024 | -2.777M |
| June 30, 2024 | -14.15M |
| March 31, 2024 | -14.47M |
| December 31, 2023 | -14.75M |
| September 30, 2023 | -9.744M |
| June 30, 2023 | -11.27M |
| March 31, 2023 | -10.57M |
| December 31, 2022 | -8.209M |
| September 30, 2022 | -6.854M |
| June 30, 2022 | -7.605M |
| March 31, 2022 | -7.034M |
| December 31, 2021 | -7.791M |
| September 30, 2021 | -8.569M |
| June 30, 2021 | -4.633M |
| March 31, 2021 | -7.217M |
| December 31, 2020 | -6.087M |
| September 30, 2020 | -6.601M |
| June 30, 2020 | -3.782M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.558M |
| December 31, 2019 | -5.304M |
| September 30, 2019 | -5.265M |
| June 30, 2019 | -0.6962M |
| March 31, 2019 | -5.168M |
| December 31, 2018 | 2.148M |
| September 30, 2018 | -10.24M |
| June 30, 2018 | -8.557M |
| March 31, 2018 | -10.19M |
| December 31, 2017 | -10.31M |
| September 30, 2017 | -9.956M |
| June 30, 2017 | -5.146M |
| March 31, 2017 | -7.597M |
| December 31, 2016 | -6.399M |
| September 30, 2016 | -9.126M |
| June 30, 2016 | -4.887M |
| March 31, 2016 | -4.118M |
| December 31, 2015 | -3.866M |
| September 30, 2015 | -4.688M |
| June 30, 2015 | -4.135M |
| March 31, 2015 | -5.498M |
| December 31, 2014 | -2.214M |
| September 30, 2014 | -5.035M |
| June 30, 2014 | 2.743M |
| March 31, 2014 | -16.71M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Innoviva, Inc. | -83.42M |
| Zevra Therapeutics, Inc. | 8.393M |
| Filana Therapeutics, Inc. | -8.603M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| Cannabis Global, Inc. | -0.062M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 101.93M |
| Total Expenses (Quarterly) | 75.94M |
| EPS Diluted (Quarterly) | 0.281 |
| Enterprise Value | 530.88M |
| Gross Profit Margin (Quarterly) | 75.66% |
| Profit Margin (Quarterly) | 25.50% |
| Earnings Yield | 25.42% |
| Operating Earnings Yield | 28.68% |
| Normalized Earnings Yield | 26.59 |